Meningitis caused by neisseria meningitidis, hemophilus influenzae type b and streptococcus pneumoniae during 2005-2012 in Turkey: A multicenter prospective surveillance study
dc.contributor.author | Ceyhan M. | |
dc.contributor.author | Gürler N.G. | |
dc.contributor.author | Ozsurekci Y. | |
dc.contributor.author | Keser M. | |
dc.contributor.author | Aycan A.E. | |
dc.contributor.author | Gurbuz V. | |
dc.contributor.author | Salman N. | |
dc.contributor.author | Camcioglu Y. | |
dc.contributor.author | Dinleyici E.C. | |
dc.contributor.author | Ozkan S. | |
dc.contributor.author | Sensoy G. | |
dc.contributor.author | Belet N. | |
dc.contributor.author | Alhan E. | |
dc.contributor.author | Hacimustafaoglu M. | |
dc.contributor.author | Celebi S. | |
dc.contributor.author | Uzun H. | |
dc.contributor.author | Oner A.F. | |
dc.contributor.author | Kurugol Z. | |
dc.contributor.author | Ali M. | |
dc.contributor.author | Aygun D. | |
dc.contributor.author | Oncel E.K. | |
dc.contributor.author | Celik M. | |
dc.contributor.author | Yasa O. | |
dc.contributor.author | Akin F. | |
dc.contributor.author | Coşkun Y. | |
dc.date.accessioned | 2019-10-27T08:21:46Z | |
dc.date.available | 2019-10-27T08:21:46Z | |
dc.date.issued | 2014 | |
dc.department | Ege Üniversitesi | en_US |
dc.description.abstract | Successful vaccination policies for protection from bacterial meningitis are dependent on determination of the etiology of bacterial meningitis. Cerebrospinal fluid (CSF) samples were obtained prospectively from children from 1 month to ? 18 years of age hospitalized with suspected meningitis, in order to determine the etiology of meningitis in Turkey. DNA evidence of Neisseria meningitidis (N. meningitidis ), Streptococcus pneumoniae ( S. pneumoniae), and Hemophilus influenzae type b (Hib) was detected using multiplex polymerase chain reaction (PCR). In total, 1452 CSF samples were evaluated and bacterial etiology was determined in 645 (44.4%) cases between 2005 and 2012; N. meningitidis was detected in 333 (51.6%), S. pneumoniae in 195 (30.2%), and Hib in 117 (18.1%) of the PCR positive samples. Of the 333 N. meningitidis positive samples 127 (38.1%) were identified as serogroup W-135, 87 (26.1%) serogroup B, 28 (8.4%) serogroup A and 3 (0.9%) serogroup Y; 88 (26.4%) were non-groupable. As vaccines against the most frequent bacterial isolates in this study are available and licensed, these results highlight the need for broad based protection against meningococcal disease in Turkey. © 2014 Taylor & Francis Group, LLC | en_US |
dc.description.sponsorship | GlaxoSmithKline, GSK | en_US |
dc.description.sponsorship | The study was supported by Novartis Vaccines and Diagnostics (for 5 years) and by GlaxoSmithKline (for 2 years). The authors declare that they have no other conflicts of interest. -- | en_US |
dc.identifier.doi | 10.4161/hv.29678 | en_US |
dc.identifier.endpage | 2712 | en_US |
dc.identifier.issn | 2164-5515 | |
dc.identifier.issue | 9 | en_US |
dc.identifier.pmid | 25483487 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 2706 | en_US |
dc.identifier.uri | https://doi.org/10.4161/hv.29678 | |
dc.identifier.uri | https://hdl.handle.net/11454/26103 | |
dc.identifier.volume | 10 | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Landes Bioscience | en_US |
dc.relation.ispartof | Human Vaccines and Immunotherapeutics | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Epidemiology | en_US |
dc.subject | Etiologic agents | en_US |
dc.subject | Hib | en_US |
dc.subject | Meningitis | en_US |
dc.subject | N. meningitidis | en_US |
dc.subject | S. pneumoniae | en_US |
dc.subject | Surveillance | en_US |
dc.subject | Turkey | en_US |
dc.title | Meningitis caused by neisseria meningitidis, hemophilus influenzae type b and streptococcus pneumoniae during 2005-2012 in Turkey: A multicenter prospective surveillance study | en_US |
dc.type | Article | en_US |